|
Market Cap (4-Jun) $5,403,732 (1,096th) |
Close (30-Jun) $0.026 |
Volume (30-Jun) 3,174,615 |
Shortsold (20-Nov) 421,583 (0.03%) (497th) |
|
52w High $0.005 |
52w Low $0.002 |
P/E 11.92 |
EPS 0 |
BIT released this announcement to the ASX on 28 January 2022, 8:38. The announcement is marked as price sensitive, and is 5 page(s) in length and 248.82kb in size.
You can view all announcements from BIT and see how they appear on a price chart on the announcements page.
At the date of this announcement, BIT was 0.019% short sold according to ASIC data. It was ranked the 586th most shorted stock on the ASX. It is now ranked as the 497th most shorted stock on the ASX with 0.028% of total shares short sold as of the latest reported data (20 November 2025).
| Other Recent Announcements from BIT | |
|---|---|
| Second Site Approved for Phase 2 Covid-19 Trial | 12 May 2023, 10:16 |
| Commencement Phase 2 Covid-19 Clinical Trial | 4 May 2023, 9:15 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 27 April 2023, 11:00 |
| Quarterly Appendix 4C Cash Flow Report | 28 January 2022, 8:38 |
| Update on Biotron HIV-1 And COVID-19 Programs | 16 December 2021, 11:53 |
| Notification of cessation of securities - BIT | 6 December 2021, 10:59 |
| BIOTRON DRUG EFFECTIVE AGAINST COVID-19 IN ANIMALS | 25 November 2021, 9:19 |
You must be logged in to post a reply.
Biotron 